换一批
换一批Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.
作者：
Dale W,Garsed [1]
;
Kathryn,Alsop [2]
;
Sian,Fereday [1]
;
Catherine,Emmanuel [1]
;
Catherine J,Kennedy [3]
;
Dariush,Etemadmoghadam [4]
;
Bo,Gao [5]
;
Val,Gebski [3]
;
Valérie,Garès [4]
;
Elizabeth L,Christie [1]
;
Maartje C A,Wouters [2]
;
Katy,Milne [6]
;
Joshy,George [3]
;
Ann-Marie,Patch [7]
;
Jason,Li [8]
;
Gisela Mir,Arnau [8]
;
Timothy,Semple [1]
;
Sreeja R,Gadipally [2]
;
Yoke-Eng,Chiew [9]
;
Joy,Hendley [9]
;
Thomas,Mikeska [10]
;
Giada V,Zapparoli [11]
;
Kaushalya,Amarasinghe [1]
;
Sean M,Grimmond [2]
;
John V,Pearson [1]
;
Nicola,Waddell [1]
;
Jillian,Hung [1]
;
Colin J R,Stewart [3]
;
Raghwa,Sharma [4]
;
Prue E,Allan [1]
;
Peter F,Rambau [12]
;
Orla,McNally [13]
;
Linda,Mileshkin [12]
;
Anne,Hamilton [13]
;
Sumitra,Ananda [1]
;
Marisa,Grossi [14]
;
Paul A,Cohen [11]
;
Yee C,Leung [11]
;
Robert M,Rome [4]
;
Philip,Beale [15]
;
Penny,Blomfield [16]
;
Michael,Friedlander [5]
;
Alison,Brand [1]
;
Alexander,Dobrovic [17]
;
Martin,Köbel [18]
;
Paul,Harnett [19]
;
Brad H,Nelson [1]
;
David D L,Bowtell [2]
;
Anna,deFazio [1]
;
Nadia Traficante, for the Australian Ovarian Cancer Study Group [19]
作者单位：
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[1]
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
[2]
Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
[3]
Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
[4]
The University of Sydney, Sydney, New South Wales, Australia.
[5]
Department of Pathology, University of Melbourne, Victoria, Australia.
[6]
Crown Princess Mary Cancer Care Centre, Westmead Hospital, Sydney, New South Wales, Australia.
[7]
NHMRC Clinical Trials Centre, Sydney, New South Wales, Australia.
[8]
Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.
[9]
The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut.
[10]
QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
[11]
Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
[12]
School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.
[13]
University of Melbourne Centre for Cancer Research, The University of Melbourne, Victoria, Australia.
[14]
Department of Histopathology, King Edward Memorial Hospital, Perth and the University of Western Australia, Crawley, Western Australia, Australia.
[15]
Department of Anatomical Pathology, Westmead Hospital, Westmead, New South Wales, Australia.
[16]
Department of Pathology and Laboratory Medicine, Foothill Medical Center, University of Calgary, Calgary, Canada.
[17]
Department of Obstetrics and Gynaecology, The University of Melbourne, Victoria, Australia.
[18]
The Royal Women's Hospital, Parkville, Victoria, Australia.
[19]
Department of Medicine, The University of Melbourne, Victoria, Australia.
[20]
St John of God Hospital Bendat Family Comprehensive Cancer Centre, Subiaco, Western Australia, Australia.
[21]
The Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia.
[22]
School of Women's and Infants' Health, University of Western Australia, Crawley, Western Australia, Australia.
[23]
Obstetrics and Gynaecology Institute, Epworth Freemasons Hospital, Melbourne, Victoria, Australia.
[24]
Concord Hospital, Sydney, New South Wales, Australia.
[25]
Department of Obstetrics and Gynaecology, The Royal Hobart Hospital, Hobart, Tasmania, Australia.
[26]
Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
[27]
Department of Pathology, The University of Melbourne, Victoria, Australia.
[28]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. david.bowtell@petermac.org.
[29]
Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
[30]
Department of Biochemistry and Molecular Biology, The University of Melbourne, Victoria, Australia.
[31]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);囊腺癌, 浆液(Cystadenocarcinoma, Serous);女(雌)性(Female);人类(Humans);中年人(Middle Aged);突变(Mutation);肿瘤分期(Neoplasm Staging);卵巢肿瘤(Ovarian Neoplasms);预后(Prognosis);视网膜母细胞瘤蛋白质(Retinoblastoma Protein);信号传导(Signal Transduction);存活率分析(Survival Analysis)
DOI
10.1158/1078-0432.CCR-17-1621
PMID
29061645
发布时间
2019-07-24
- 浏览11
Clinical cancer research
Clinical cancer research
569-580页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
